Resverlogix Corp.
Resverlogix Corp. RVX.TO Peers
See (RVX.TO) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RVX.TO | $0.04 | +12.50% | 11.34M | -1.00 | -$0.04 | N/A |
| BLU.TO | $19.48 | -0.10% | 2.47B | -20.29 | -$0.96 | N/A |
| MMED.NE | $14.90 | +9.48% | 1.05B | -4.50 | -$3.31 | N/A |
| DRUG.CN | $45.23 | +6.77% | 318.60M | -226.15 | -$0.20 | N/A |
| FRX.TO | $9.50 | +9.70% | 262.18M | -316.67 | -$0.03 | N/A |
| CYBN.NE | $9.31 | +1.75% | 195.76M | -1.88 | -$4.96 | N/A |
| EPRX.TO | $5.35 | +1.33% | 191.79M | -5.05 | -$1.06 | N/A |
| MSCL.TO | $0.63 | -1.56% | 96.63M | 2.52 | $0.25 | N/A |
| MDNA.TO | $1.13 | +5.61% | 88.38M | -3.05 | -$0.37 | N/A |
| GLAB.CN | $1.03 | +15.73% | 77.11M | -20.60 | -$0.05 | N/A |
Stock Comparison
RVX.TO vs BLU.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, BLU.TO has a market cap of 2.47B. Regarding current trading prices, RVX.TO is priced at $0.04, while BLU.TO trades at $19.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas BLU.TO's P/E ratio is -20.29. In terms of profitability, RVX.TO's ROE is +0.06%, compared to BLU.TO's ROE of -0.22%. Regarding short-term risk, RVX.TO is more volatile compared to BLU.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MMED.NE Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MMED.NE has a market cap of 1.05B. Regarding current trading prices, RVX.TO is priced at $0.04, while MMED.NE trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MMED.NE's P/E ratio is -4.50. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MMED.NE's ROE of -0.33%. Regarding short-term risk, RVX.TO is less volatile compared to MMED.NE. This indicates potentially lower risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs DRUG.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, DRUG.CN has a market cap of 318.60M. Regarding current trading prices, RVX.TO is priced at $0.04, while DRUG.CN trades at $45.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas DRUG.CN's P/E ratio is -226.15. In terms of profitability, RVX.TO's ROE is +0.06%, compared to DRUG.CN's ROE of -0.06%. Regarding short-term risk, RVX.TO is more volatile compared to DRUG.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs FRX.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, FRX.TO has a market cap of 262.18M. Regarding current trading prices, RVX.TO is priced at $0.04, while FRX.TO trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas FRX.TO's P/E ratio is -316.67. In terms of profitability, RVX.TO's ROE is +0.06%, compared to FRX.TO's ROE of +0.19%. Regarding short-term risk, RVX.TO is less volatile compared to FRX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs CYBN.NE Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, CYBN.NE has a market cap of 195.76M. Regarding current trading prices, RVX.TO is priced at $0.04, while CYBN.NE trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas CYBN.NE's P/E ratio is -1.88. In terms of profitability, RVX.TO's ROE is +0.06%, compared to CYBN.NE's ROE of -0.39%. Regarding short-term risk, RVX.TO is more volatile compared to CYBN.NE. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs EPRX.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, EPRX.TO has a market cap of 191.79M. Regarding current trading prices, RVX.TO is priced at $0.04, while EPRX.TO trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas EPRX.TO's P/E ratio is -5.05. In terms of profitability, RVX.TO's ROE is +0.06%, compared to EPRX.TO's ROE of -1.21%. Regarding short-term risk, RVX.TO is more volatile compared to EPRX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MSCL.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MSCL.TO has a market cap of 96.63M. Regarding current trading prices, RVX.TO is priced at $0.04, while MSCL.TO trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MSCL.TO's P/E ratio is 2.52. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MSCL.TO's ROE of -0.74%. Regarding short-term risk, RVX.TO is more volatile compared to MSCL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MDNA.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MDNA.TO has a market cap of 88.38M. Regarding current trading prices, RVX.TO is priced at $0.04, while MDNA.TO trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MDNA.TO's P/E ratio is -3.05. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MDNA.TO's ROE of -1.64%. Regarding short-term risk, RVX.TO is more volatile compared to MDNA.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs GLAB.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, GLAB.CN has a market cap of 77.11M. Regarding current trading prices, RVX.TO is priced at $0.04, while GLAB.CN trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas GLAB.CN's P/E ratio is -20.60. In terms of profitability, RVX.TO's ROE is +0.06%, compared to GLAB.CN's ROE of +1.38%. Regarding short-term risk, RVX.TO is more volatile compared to GLAB.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MSET.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MSET.CN has a market cap of 74.96M. Regarding current trading prices, RVX.TO is priced at $0.04, while MSET.CN trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MSET.CN's P/E ratio is -12.33. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MSET.CN's ROE of -3.17%. Regarding short-term risk, Volatility data is not available for a full comparison. RVX.TO has daily volatility of 11.76 and MSET.CN has daily volatility of N/A.
RVX.TO vs SVA.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, SVA.TO has a market cap of 65.70M. Regarding current trading prices, RVX.TO is priced at $0.04, while SVA.TO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas SVA.TO's P/E ratio is -2.22. In terms of profitability, RVX.TO's ROE is +0.06%, compared to SVA.TO's ROE of +2.30%. Regarding short-term risk, RVX.TO is more volatile compared to SVA.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs ONCO.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, ONCO.CN has a market cap of 64.63M. Regarding current trading prices, RVX.TO is priced at $0.04, while ONCO.CN trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas ONCO.CN's P/E ratio is -149.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to ONCO.CN's ROE of N/A. Regarding short-term risk, RVX.TO is more volatile compared to ONCO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs ONC.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, ONC.TO has a market cap of 56.17M. Regarding current trading prices, RVX.TO is priced at $0.04, while ONC.TO trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas ONC.TO's P/E ratio is -1.59. In terms of profitability, RVX.TO's ROE is +0.06%, compared to ONC.TO's ROE of -2.25%. Regarding short-term risk, RVX.TO is more volatile compared to ONC.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs PMN.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, PMN.TO has a market cap of 51.48M. Regarding current trading prices, RVX.TO is priced at $0.04, while PMN.TO trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas PMN.TO's P/E ratio is -1.78. In terms of profitability, RVX.TO's ROE is +0.06%, compared to PMN.TO's ROE of -5.57%. Regarding short-term risk, RVX.TO is more volatile compared to PMN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs HBP.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, HBP.TO has a market cap of 50.90M. Regarding current trading prices, RVX.TO is priced at $0.04, while HBP.TO trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas HBP.TO's P/E ratio is -0.91. In terms of profitability, RVX.TO's ROE is +0.06%, compared to HBP.TO's ROE of +21.43%. Regarding short-term risk, RVX.TO is more volatile compared to HBP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs DTC.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, DTC.CN has a market cap of 50.35M. Regarding current trading prices, RVX.TO is priced at $0.04, while DTC.CN trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas DTC.CN's P/E ratio is -10.22. In terms of profitability, RVX.TO's ROE is +0.06%, compared to DTC.CN's ROE of +1.22%. Regarding short-term risk, RVX.TO is more volatile compared to DTC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MBX.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MBX.TO has a market cap of 49.28M. Regarding current trading prices, RVX.TO is priced at $0.04, while MBX.TO trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MBX.TO's P/E ratio is 35.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MBX.TO's ROE of +0.07%. Regarding short-term risk, RVX.TO is more volatile compared to MBX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs IGX.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, IGX.TO has a market cap of 41.92M. Regarding current trading prices, RVX.TO is priced at $0.04, while IGX.TO trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas IGX.TO's P/E ratio is -3.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to IGX.TO's ROE of +0.93%. Regarding short-term risk, RVX.TO is more volatile compared to IGX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs AEZS.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, AEZS.TO has a market cap of 25.38M. Regarding current trading prices, RVX.TO is priced at $0.04, while AEZS.TO trades at $8.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas AEZS.TO's P/E ratio is -2.61. In terms of profitability, RVX.TO's ROE is +0.06%, compared to AEZS.TO's ROE of -0.67%. Regarding short-term risk, RVX.TO is more volatile compared to AEZS.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs DOSE.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, DOSE.CN has a market cap of 25.05M. Regarding current trading prices, RVX.TO is priced at $0.04, while DOSE.CN trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas DOSE.CN's P/E ratio is -4.87. In terms of profitability, RVX.TO's ROE is +0.06%, compared to DOSE.CN's ROE of +1.61%. Regarding short-term risk, RVX.TO is more volatile compared to DOSE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs BCT.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, BCT.TO has a market cap of 23.32M. Regarding current trading prices, RVX.TO is priced at $0.04, while BCT.TO trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas BCT.TO's P/E ratio is -0.62. In terms of profitability, RVX.TO's ROE is +0.06%, compared to BCT.TO's ROE of +66.06%. Regarding short-term risk, RVX.TO is more volatile compared to BCT.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs PHRM.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, PHRM.CN has a market cap of 18.15M. Regarding current trading prices, RVX.TO is priced at $0.04, while PHRM.CN trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas PHRM.CN's P/E ratio is -4.10. In terms of profitability, RVX.TO's ROE is +0.06%, compared to PHRM.CN's ROE of -0.83%. Regarding short-term risk, RVX.TO is less volatile compared to PHRM.CN. This indicates potentially lower risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs REUN.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, REUN.TO has a market cap of 16.64M. Regarding current trading prices, RVX.TO is priced at $0.04, while REUN.TO trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas REUN.TO's P/E ratio is -0.43. In terms of profitability, RVX.TO's ROE is +0.06%, compared to REUN.TO's ROE of -1.10%. Regarding short-term risk, RVX.TO is more volatile compared to REUN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs PREV.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, PREV.CN has a market cap of 16.25M. Regarding current trading prices, RVX.TO is priced at $0.04, while PREV.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas PREV.CN's P/E ratio is -30.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to PREV.CN's ROE of +0.19%. Regarding short-term risk, RVX.TO is less volatile compared to PREV.CN. This indicates potentially lower risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs TELI.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, TELI.CN has a market cap of 14.50M. Regarding current trading prices, RVX.TO is priced at $0.04, while TELI.CN trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas TELI.CN's P/E ratio is -9.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to TELI.CN's ROE of -2.08%. Regarding short-term risk, RVX.TO is more volatile compared to TELI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs BETR.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, BETR.CN has a market cap of 14.25M. Regarding current trading prices, RVX.TO is priced at $0.04, while BETR.CN trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas BETR.CN's P/E ratio is -3.67. In terms of profitability, RVX.TO's ROE is +0.06%, compared to BETR.CN's ROE of +0.43%. Regarding short-term risk, RVX.TO is more volatile compared to BETR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs IMV.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, IMV.TO has a market cap of 13.12M. Regarding current trading prices, RVX.TO is priced at $0.04, while IMV.TO trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas IMV.TO's P/E ratio is -0.18. In terms of profitability, RVX.TO's ROE is +0.06%, compared to IMV.TO's ROE of -4.95%. Regarding short-term risk, RVX.TO is more volatile compared to IMV.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MDMA.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MDMA.CN has a market cap of 12.26M. Regarding current trading prices, RVX.TO is priced at $0.04, while MDMA.CN trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MDMA.CN's P/E ratio is -7.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MDMA.CN's ROE of -0.86%. Regarding short-term risk, RVX.TO is more volatile compared to MDMA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs GLOW.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, GLOW.CN has a market cap of 11.22M. Regarding current trading prices, RVX.TO is priced at $0.04, while GLOW.CN trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas GLOW.CN's P/E ratio is -2.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to GLOW.CN's ROE of +12.80%. Regarding short-term risk, RVX.TO is more volatile compared to GLOW.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs TBP.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, TBP.TO has a market cap of 10.58M. Regarding current trading prices, RVX.TO is priced at $0.04, while TBP.TO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas TBP.TO's P/E ratio is -0.31. In terms of profitability, RVX.TO's ROE is +0.06%, compared to TBP.TO's ROE of -4.68%. Regarding short-term risk, RVX.TO is more volatile compared to TBP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs BLAB.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, BLAB.CN has a market cap of 10.55M. Regarding current trading prices, RVX.TO is priced at $0.04, while BLAB.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas BLAB.CN's P/E ratio is -1.30. In terms of profitability, RVX.TO's ROE is +0.06%, compared to BLAB.CN's ROE of -4.53%. Regarding short-term risk, RVX.TO is more volatile compared to BLAB.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs BIOV.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, BIOV.CN has a market cap of 10.20M. Regarding current trading prices, RVX.TO is priced at $0.04, while BIOV.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas BIOV.CN's P/E ratio is -1.75. In terms of profitability, RVX.TO's ROE is +0.06%, compared to BIOV.CN's ROE of +4.49%. Regarding short-term risk, RVX.TO is more volatile compared to BIOV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MCUR.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MCUR.CN has a market cap of 7.04M. Regarding current trading prices, RVX.TO is priced at $0.04, while MCUR.CN trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MCUR.CN's P/E ratio is -0.75. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MCUR.CN's ROE of -1.61%. Regarding short-term risk, RVX.TO is more volatile compared to MCUR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs COOL.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, COOL.CN has a market cap of 6.83M. Regarding current trading prices, RVX.TO is priced at $0.04, while COOL.CN trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas COOL.CN's P/E ratio is -1.32. In terms of profitability, RVX.TO's ROE is +0.06%, compared to COOL.CN's ROE of -2.90%. Regarding short-term risk, RVX.TO is more volatile compared to COOL.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs APS.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, APS.TO has a market cap of 6.02M. Regarding current trading prices, RVX.TO is priced at $0.04, while APS.TO trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas APS.TO's P/E ratio is -0.10. In terms of profitability, RVX.TO's ROE is +0.06%, compared to APS.TO's ROE of +3.67%. Regarding short-term risk, RVX.TO is more volatile compared to APS.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs TRYP.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, TRYP.CN has a market cap of 5.79M. Regarding current trading prices, RVX.TO is priced at $0.04, while TRYP.CN trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas TRYP.CN's P/E ratio is -1.50. In terms of profitability, RVX.TO's ROE is +0.06%, compared to TRYP.CN's ROE of +1.31%. Regarding short-term risk, RVX.TO is more volatile compared to TRYP.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs ASEP.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, ASEP.CN has a market cap of 5.56M. Regarding current trading prices, RVX.TO is priced at $0.04, while ASEP.CN trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas ASEP.CN's P/E ratio is -0.83. In terms of profitability, RVX.TO's ROE is +0.06%, compared to ASEP.CN's ROE of -0.40%. Regarding short-term risk, RVX.TO is more volatile compared to ASEP.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs CMND.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, CMND.CN has a market cap of 5.07M. Regarding current trading prices, RVX.TO is priced at $0.04, while CMND.CN trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas CMND.CN's P/E ratio is -0.04. In terms of profitability, RVX.TO's ROE is +0.06%, compared to CMND.CN's ROE of -0.46%. Regarding short-term risk, RVX.TO is more volatile compared to CMND.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs GTTX.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, GTTX.CN has a market cap of 4.65M. Regarding current trading prices, RVX.TO is priced at $0.04, while GTTX.CN trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas GTTX.CN's P/E ratio is -12.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to GTTX.CN's ROE of -0.60%. Regarding short-term risk, RVX.TO is more volatile compared to GTTX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs AWKN.NE Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, AWKN.NE has a market cap of 3.86M. Regarding current trading prices, RVX.TO is priced at $0.04, while AWKN.NE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas AWKN.NE's P/E ratio is -0.36. In terms of profitability, RVX.TO's ROE is +0.06%, compared to AWKN.NE's ROE of +2.31%. Regarding short-term risk, RVX.TO is more volatile compared to AWKN.NE. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs APLI.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, APLI.TO has a market cap of 3.64M. Regarding current trading prices, RVX.TO is priced at $0.04, while APLI.TO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas APLI.TO's P/E ratio is -1.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to APLI.TO's ROE of +0.32%. Regarding short-term risk, RVX.TO is more volatile compared to APLI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MYND.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MYND.CN has a market cap of 3.35M. Regarding current trading prices, RVX.TO is priced at $0.04, while MYND.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MYND.CN's P/E ratio is -3.50. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MYND.CN's ROE of +0.18%. Regarding short-term risk, RVX.TO is less volatile compared to MYND.CN. This indicates potentially lower risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs IPCI.TO Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, IPCI.TO has a market cap of 2.65M. Regarding current trading prices, RVX.TO is priced at $0.04, while IPCI.TO trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas IPCI.TO's P/E ratio is -0.67. In terms of profitability, RVX.TO's ROE is +0.06%, compared to IPCI.TO's ROE of +0.16%. Regarding short-term risk, RVX.TO is less volatile compared to IPCI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs AGN.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, AGN.CN has a market cap of 2.46M. Regarding current trading prices, RVX.TO is priced at $0.04, while AGN.CN trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas AGN.CN's P/E ratio is 3.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to AGN.CN's ROE of +0.15%. Regarding short-term risk, RVX.TO is more volatile compared to AGN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs MOOD.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, MOOD.CN has a market cap of 1.94M. Regarding current trading prices, RVX.TO is priced at $0.04, while MOOD.CN trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas MOOD.CN's P/E ratio is -7.17. In terms of profitability, RVX.TO's ROE is +0.06%, compared to MOOD.CN's ROE of -0.28%. Regarding short-term risk, RVX.TO is more volatile compared to MOOD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs ENBI.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, ENBI.CN has a market cap of 1.46M. Regarding current trading prices, RVX.TO is priced at $0.04, while ENBI.CN trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas ENBI.CN's P/E ratio is -2.62. In terms of profitability, RVX.TO's ROE is +0.06%, compared to ENBI.CN's ROE of -1.33%. Regarding short-term risk, RVX.TO is more volatile compared to ENBI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs BRAX.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, BRAX.CN has a market cap of 1.42M. Regarding current trading prices, RVX.TO is priced at $0.04, while BRAX.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas BRAX.CN's P/E ratio is -0.10. In terms of profitability, RVX.TO's ROE is +0.06%, compared to BRAX.CN's ROE of -2.49%. Regarding short-term risk, RVX.TO is more volatile compared to BRAX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs HAVN.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, HAVN.CN has a market cap of 1.15M. Regarding current trading prices, RVX.TO is priced at $0.04, while HAVN.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas HAVN.CN's P/E ratio is -0.01. In terms of profitability, RVX.TO's ROE is +0.06%, compared to HAVN.CN's ROE of +0.00%. Regarding short-term risk, RVX.TO is more volatile compared to HAVN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs LEXT.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, LEXT.CN has a market cap of 1.03M. Regarding current trading prices, RVX.TO is priced at $0.04, while LEXT.CN trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas LEXT.CN's P/E ratio is -0.48. In terms of profitability, RVX.TO's ROE is +0.06%, compared to LEXT.CN's ROE of -2.39%. Regarding short-term risk, RVX.TO is more volatile compared to LEXT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs CHGX.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, CHGX.CN has a market cap of 415648.00. Regarding current trading prices, RVX.TO is priced at $0.04, while CHGX.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas CHGX.CN's P/E ratio is -0.50. In terms of profitability, RVX.TO's ROE is +0.06%, compared to CHGX.CN's ROE of +0.23%. Regarding short-term risk, RVX.TO is more volatile compared to CHGX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs NSHS.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, NSHS.CN has a market cap of 411008.00. Regarding current trading prices, RVX.TO is priced at $0.04, while NSHS.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas NSHS.CN's P/E ratio is 1.00. In terms of profitability, RVX.TO's ROE is +0.06%, compared to NSHS.CN's ROE of +0.09%. Regarding short-term risk, RVX.TO is more volatile compared to NSHS.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs CURE.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, CURE.CN has a market cap of 408018.00. Regarding current trading prices, RVX.TO is priced at $0.04, while CURE.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas CURE.CN's P/E ratio is 0.17. In terms of profitability, RVX.TO's ROE is +0.06%, compared to CURE.CN's ROE of -2.58%. Regarding short-term risk, RVX.TO is more volatile compared to CURE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs ABRT.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, ABRT.CN has a market cap of 372067.00. Regarding current trading prices, RVX.TO is priced at $0.04, while ABRT.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas ABRT.CN's P/E ratio is -0.10. In terms of profitability, RVX.TO's ROE is +0.06%, compared to ABRT.CN's ROE of +16.27%. Regarding short-term risk, RVX.TO is more volatile compared to ABRT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs WBIO.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, WBIO.CN has a market cap of 324764.00. Regarding current trading prices, RVX.TO is priced at $0.04, while WBIO.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas WBIO.CN's P/E ratio is 0.41. In terms of profitability, RVX.TO's ROE is +0.06%, compared to WBIO.CN's ROE of +0.01%. Regarding short-term risk, RVX.TO is more volatile compared to WBIO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs NIRV.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, NIRV.CN has a market cap of 289398.00. Regarding current trading prices, RVX.TO is priced at $0.04, while NIRV.CN trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas NIRV.CN's P/E ratio is -0.30. In terms of profitability, RVX.TO's ROE is +0.06%, compared to NIRV.CN's ROE of +0.00%. Regarding short-term risk, RVX.TO is more volatile compared to NIRV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.
RVX.TO vs NOVA.CN Comparison
RVX.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVX.TO stands at 11.34M. In comparison, NOVA.CN has a market cap of 148319.00. Regarding current trading prices, RVX.TO is priced at $0.04, while NOVA.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVX.TO currently has a P/E ratio of -1.00, whereas NOVA.CN's P/E ratio is -0.05. In terms of profitability, RVX.TO's ROE is +0.06%, compared to NOVA.CN's ROE of -0.02%. Regarding short-term risk, RVX.TO is more volatile compared to NOVA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for RVX.TO.